{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-235949","form_type":"8-K","ticker":"OSRH","cik":"0001840425","company_name":"OSR Holdings, Inc.","filed_at":"2024-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.966348+00:00","generated_at":"2026-05-30T16:51:42.633658+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Nasdaq panel grants Bellevue Life Sciences continued listing; must meet public holders rule by Feb 2025","bullets":["Received Nasdaq notice Feb 2024 for failing minimum 300 public holders; plan approved with extension to Aug 13, 2024.","Did not regain compliance by Aug 13; requested hearing which stayed suspension.","Hearing held Oct 1, 2024; Panel granted continued listing on Oct 4, 2024.","Must demonstrate compliance with Listing Rule 5505 by Feb 17, 2025, with prompt notification."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-235949","json":"https://secwatch.observer/filing/0001193125-24-235949.json","markdown":"https://secwatch.observer/filing/0001193125-24-235949.md","text":"https://secwatch.observer/filing/0001193125-24-235949.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840425/000119312524235949/0001193125-24-235949-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840425/000119312524235949/d846929d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T16:51:42.633658+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}